Tag: Supply Chain


  • Issued June 14, 2026 · Trade Policy Analysis The headline action On Monday, June 1, 2026, President Donald Trump signed a proclamation that, for the first time in this tariff cycle, moves a major category of capital goods in the opposite direction from the rest of his trade agenda. The order reduces the duty applied…

  • Peacock Tariff Consulting · June 2026 On 9 June 2026, DSV did something that, on its face, looks like a routine logistics announcement: the world’s largest freight forwarder opened a dedicated pharmaceutical air corridor between Luxembourg and Indianapolis. A new lane, a new hub, a press release full of the usual language about visibility, reliability…

  • An analysis of the benefits and costs of the agreement entering annual review, written July 1, 2026 Executive Summary On July 1, 2026 – the sixth anniversary of the Canada-United States-Mexico Agreement’s entry into force – the mandated joint review under Article 34.7 concluded without the unanimous confirmation required to extend the agreement for a…

  • An analysis of the benefits and costs of the agreement entering annual review, from the perspective of binational manufacturers operating plants in both Canada and the United States – July 1, 2026 Executive Summary On July 1, 2026, the joint review mandated by Article 34.7 of the Canada-United States-Mexico Agreement concluded without the unanimous confirmation…

  • U.S. Proposes Tariffs on 60 Economies Over Forced-Labor Trade Failures

    The United States moved to open a sweeping new front in its trade agenda this week, with the U.S. Trade Representative determining that 60 economies together accounting for the overwhelming majority of America’s imports have failed to ban and enforce prohibitions on goods made with forced labor, and proposing additional tariffs of up to 12.5%…

  • Lilly Doubles Down on Lebanon: $4.5 Billion More for Indiana

    A window into how Washington is now buying American pharmaceutical capacity and what the Lebanon expansion tells us about the new U.S. industrial-policy architecture for pharma Eli Lilly is making another major investment in U.S. manufacturing, announcing plans to spend an additional $4.5 billion at two of its sites in Lebanon, Indiana. The headline figure…

  • Introduction: The Nearshoring Imperative Nearshoring, the practice of moving manufacturing and sourcing operations from distant overseas locations to closer countries, has emerged as one of the most significant supply chain trends of the decade. Driven by tariff pressures, supply chain disruption risk, rising logistics costs, and a desire for greater operational control, businesses across industries…

  • Introduction: Paying Duty on the Right Price When goods pass through multiple intermediaries before reaching the U.S. importer, each transaction adds a markup. Under the default customs valuation rules, duties are assessed on the final transaction value: the price the U.S. importer pays to the foreign seller. But if there is an earlier sale in…

  • The Reciprocal Tariff Era Reciprocal tariffs mirror the rates other countries impose on U.S. exports. In practice, they have created a complex, multi-layered environment that changes frequently and affects different products and countries differently. Current State of Reciprocal Tariffs Actions have been taken against a broad range of trading partners under several legal authorities. Some…

  • Tariffs as a Supply Chain Risk Factor When tariff rates can change by 25 percentage points in weeks, tariffs become a dynamic risk factor demanding the same attention as any other supply chain threat. Tariff risk is driven by identifiable political and economic forces that can be anticipated and managed. Identifying Your Tariff Risk Exposures…